Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries-Reference-Cited by-同舟云学术

Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries

Published:2022-04-19 Issue:7 Volume:24 Page:1277-1287
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Norhammar Anna¹²,Bodegard Johan³^ORCID,Eriksson Jan W.⁴^ORCID,Haller Hermann⁵,Linssen Gerard C. M.⁶,Banerjee Amitava⁷⁸,Karasik Avraham⁹,Mamouris Pavlos¹⁰,Tangri Navdeep¹¹,Taveira‐Gomes Tiago¹²,Maggioni Aldo P.¹³¹⁴,Botana Manuel¹⁵,Thuresson Marcus¹⁶,Okami Suguru¹⁷^ORCID,Yajima Toshitaka¹⁷,Kadowaki Takashi¹⁸,Birkeland Kåre I.¹⁹^ORCID,

Affiliation:

1. Cardiology Unit, Department of Medicine Solna, Karolinska Institute Stockholm Sweden

2. Capio St Görans Hospital Stockholm Sweden

3. AstraZeneca Oslo Norway

4. Department of Medical Sciences, Clinical Diabetes and Metabolism Uppsala University Uppsala Sweden

5. Division of Nephrology Hannover Medical School Hannover Germany

6. Department of Cardiology Hospital Group Twente Almelo and Hengelo The Netherlands

7. Institute of Health Informatics University College London London UK

8. Department of Cardiology University College London Hospitals London UK

9. Maccabi Institute for Research and Innovation Maccabi Healthcare Services Tel Aviv Israel

10. Academic Center for General Practice KU Leuven Leuven Belgium

11. Department of Medicine and Community Health Sciences University of Manitoba Winnipeg Canada

12. Department of Community Medicine, Information and Decision in Health Faculty of Medicine, University of Porto Porto Portugal

13. ANMCO Research Centre Florence Italy

14. Maria Cecilia Hospital GVM Care and Research Cotignola Italy

15. Endocrinology Service Lucus Augusti University Hospital Lugo Spain

16. Statisticon AB Uppsala Sweden

17. AstraZeneca Osaka Japan

18. Tranomon Hospital Tokyo Japan

19. Department of Transplantation Medicine Oslo University Hospital and University of Oslo Oslo Norway

Funder

AstraZeneca AB

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14698

Reference33 articles.

1. Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study

2. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition

3. Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study

4. Epidemiology and resource use in Spanish type 2 diabetes patients without previous cardiorenal disease: CaReMe Spain study summary

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims database;Cardiovascular Diabetology;2024-01-09

2. Comparison of clinical characteristics and disease burden between early- and late-onset type 2 diabetes patients: a population-based cohort study;BMC Public Health;2023-12-04

3. Construction and validation of a risk prediction model for acute kidney injury in patients after cardiac arrest;Renal Failure;2023-11-23

4. Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims database;2023-10-09

5. Mortality, Outcomes, Costs, and Use of Medicines Following a First Heart Failure Hospitalization;JACC: Heart Failure;2023-10